Round Table Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-16,080
Closed -$827K – 113
2017
Q4
$827K Sell
16,080
-106,050
-87% -$5.45M 0.29% 40
2017
Q3
$6.36M Sell
122,130
-12,027
-9% -$617K 2.27% 14
2017
Q2
$6.94M Sell
134,157
-12,192
-8% -$616K 2.52% 12
2017
Q1
$7.36M Buy
146,349
+873
+0.6% +$43.2K 2.65% 13
2016
Q4
$6.86M Buy
+145,476
New +$6.9M 2.79% 15

Other funds holding IHE

Round Table Services's IHE Position: Q1 2018 in Review

Round Table Services sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2018, closing a stake of 16,080 shares — an estimated $827K sold.

Round Table Services first reported a position in IHE in Q4 2016 and held it in 5 quarters. The position peaked at $7.36M in Q1 2017. 101 funds tracked by Wall St. Rank hold IHE as of Q1 2018.

  • Round Table Services reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2018 after selling out during the quarter.
  • Round Table Services sold 16,080 iShares US Pharmaceuticals ETF shares in Q1 2018, an estimated $827K.
  • Round Table Services first reported a position in iShares US Pharmaceuticals ETF in Q4 2016 and held it in 5 quarters.
  • Round Table Services's iShares US Pharmaceuticals ETF position peaked at $7.36M in Q1 2017.
  • 101 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2018.

Based on Round Table Services's 13F filing for Q1 2018, filed 26 Apr 2018.